{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:30:05Z","timestamp":1792715405885,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T00:00:00Z","timestamp":1374624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.yjmcc.2013.07.011","type":"journal-article","created":{"date-parts":[[2013,7,26]],"date-time":"2013-07-26T15:11:22Z","timestamp":1374851482000},"page":"189-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice"],"prefix":"10.1016","volume":"63","author":[{"given":"Andrea","family":"St\u00f6hr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix W.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Flenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Geertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Schaaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc N.","family":"Hirt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June","family":"Uebeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Schlossarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Eschenhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2013.07.011_bb0005","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/HCO.0b013e3283375698","article-title":"Genetics of hypertrophic cardiomyopathy","volume":"25","author":"Konno","year":"2010","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0020","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.2174\/138920112804583041","article-title":"Genetics of hypertrophic and dilated cardiomyopathy","volume":"13","author":"Friedrich","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0025","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.yjmcc.2011.01.014","article-title":"Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities","volume":"50","author":"Schlossarek","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0030","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra0902923","article-title":"Inherited cardiomyopathies","volume":"364","author":"Watkins","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0035","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/j.jtcvs.2011.10.020","article-title":"ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"142","author":"Gersh","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0040","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1136\/hrt.2010.200402","article-title":"Insights into genotype\u2013phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3","volume":"96","author":"Oliva-Sandoval","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0045","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2362.2010.02268.x","article-title":"Hypertrophic cardiomyopathy: from genetics to treatment","volume":"40","author":"Marian","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0050","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1093\/eurheartj\/ehp153","article-title":"A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy","volume":"30","author":"Friedrich","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jcmg.2008.08.003","article-title":"Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations","volume":"2","author":"Michels","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/eurheartj\/ehn538","article-title":"Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis","volume":"30","author":"Cambronero","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0065","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0070","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa0908679","article-title":"Patient-specific induced pluripotent stem-cell models for long-QT syndrome","volume":"363","author":"Moretti","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature09747","article-title":"Modelling the long QT syndrome with induced pluripotent stem cells","volume":"471","author":"Itzhaki","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0080","doi-asserted-by":"crossref","first-page":"130ra47","DOI":"10.1126\/scitranslmed.3003552","article-title":"Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy","volume":"4","author":"Sun","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","article-title":"Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells","volume":"12","author":"Lan","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/CIRCRESAHA.109.211458","article-title":"Development of a drug screening platform based on engineered heart tissue","volume":"107","author":"Hansen","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0095","doi-asserted-by":"crossref","first-page":"e26397","DOI":"10.1371\/journal.pone.0026397","article-title":"Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology","volume":"6","author":"Schaaf","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/CIRCRESAHA.109.201251","article-title":"Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice","volume":"105","author":"Vignier","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0105","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.yjmcc.2012.03.009","article-title":"Increased myofilament Ca(2+) sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice","volume":"52","author":"Fraysse","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0110","first-page":"3893","article-title":"Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice","volume":"118","author":"Baudenbacher","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0115","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.RES.73.6.981","article-title":"Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments","volume":"73","author":"Solaro","year":"1993","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0120","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1113\/jphysiol.2004.062539","article-title":"Roles of phosphorylation of myosin binding protein-C and troponin I in mouse cardiac muscle twitch dynamics","volume":"558","author":"Tong","year":"2004","journal-title":"J Physiol"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0125","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/CIRCRESAHA.107.158774","article-title":"Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes","volume":"101","author":"Pohlmann","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCRESAHA.111.242354","article-title":"Neonatal mouse-derived engineered cardiac tissue: a novel model system for studying genetic heart disease","volume":"109","author":"de Lange","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1085\/jgp.201210837","article-title":"Ablation of cardiac myosin-binding protein-C accelerates contractile kinetics in engineered cardiac tissue","volume":"141","author":"de Lange","year":"2013","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00395-012-0307-z","article-title":"Increased afterload induces pathological cardiac hypertrophy: a new in vitro model","volume":"107","author":"Hirt","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0145","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0025-6196(11)60890-2","article-title":"Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy","volume":"83","author":"Olivotto","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0150","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/cvr\/cvp247","article-title":"The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy","volume":"85","author":"Carrier","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0155","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.RES.0000012222.70819.64","article-title":"Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice","volume":"90","author":"Harris","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cardiores.2004.04.009","article-title":"Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice","volume":"63","author":"Carrier","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0165","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1529\/biophysj.107.127787","article-title":"Cardiac myosin-binding protein C modulates the tuning of the molecular motor in the heart","volume":"95","author":"Lecarpentier","year":"2008","journal-title":"Biophys J"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0170","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/01.RES.0000126898.95550.31","article-title":"Role of cardiac myosin binding protein C in sustaining left ventricular systolic stiffening","volume":"94","author":"Palmer","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2013.07.011_bb0175","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1038\/mtna.2013.31","article-title":"Repair of Mybpc3 mRNA by 5\u2032-trans-splicing in a mouse model of hypertrophic cardiomyopathy","volume":"2","author":"Mearini","year":"2013","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282813002332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282813002332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T09:27:58Z","timestamp":1539509278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282813002332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":35,"alternative-id":["S0022282813002332"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2013.07.011","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2013.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}